11 min listen
E53: Another Look at Nintedanib for SSc-ILD
E53: Another Look at Nintedanib for SSc-ILD
ratings:
Length:
15 minutes
Released:
Dec 19, 2019
Format:
Podcast episode
Description
This week I go back to a topic from episode 42, the SENSCIS trial and nintedanib for SSc-ILD. The way this medication has been received and a recent article I wrote for The Rheumatologist gave me a nice jumping off point to cover a few more issues from this. Be sure to follow me @EBRheum to let me know what you think! The corresponding article is available here: https://www.the-rheumatologist.org/article/fda-approves-nintedanib-for-ssc-ild-but-temper-your-expectations/
Released:
Dec 19, 2019
Format:
Podcast episode
Titles in the series (87)
E17: Steroids and the Risk of Scleroderma Renal Crisis: Short but impactful paper this week on the association between steroids and scleroderma renal crisis. Find the original paper here. by The Evidence Based Rheumatology Podcast